Smith Group Asset Management’s ANACOR PHARMACEUTICALS INC COM ANAC Stock Holding History

Smith Group Asset Management’s Portfolio ANAC Stock Details ANAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-8,460	Closed	-$452K	–	545
2016 Q1	$452K	Buy	8,460 +930	+12%	+$68.7K	0.01%	174
2015 Q4	$851K	Buy	7,530 +3,420	+83%	+$377K	0.03%	181
2015 Q3	$484K	Buy	+4,110	New	+$537K	0.02%	195

Other funds holding ANAC

KCM

Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return

CIM

CIM Investment Management Pittsburgh, Pennsylvania $375M AUM 32.03% 1-Year Est. Return

Smith Group Asset Management's ANAC Position: Q2 2016 in Review

Smith Group Asset Management sold out of ANACOR PHARMACEUTICALS INC COM (ANAC) in Q2 2016, closing a stake of 8,460 shares — an estimated $452K sold.

Smith Group Asset Management first reported a position in ANAC in Q3 2015 and held it in 3 quarters. The position peaked at $851K in Q4 2015. 2 funds tracked by Wall St. Rank hold ANAC as of Q2 2016.

Smith Group Asset Management reported no remaining ANACOR PHARMACEUTICALS INC COM position as of Q2 2016 after selling out during the quarter.
Smith Group Asset Management sold 8,460 ANACOR PHARMACEUTICALS INC COM shares in Q2 2016, an estimated $452K.
Smith Group Asset Management first reported a position in ANACOR PHARMACEUTICALS INC COM in Q3 2015 and held it in 3 quarters.
Smith Group Asset Management's ANACOR PHARMACEUTICALS INC COM position peaked at $851K in Q4 2015.
2 funds tracked by Wall St. Rank held ANACOR PHARMACEUTICALS INC COM as of Q2 2016.

Based on Smith Group Asset Management's 13F filing for Q2 2016, filed 26 Jul 2016.